Newsroom

Press Release - All

• 09 Mar 2021
  Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
• 03 Mar 2021
  Agilent Technologies Announces Proposed Offering of Senior Notes
• 03 Mar 2021
  Agilent Technologies Announces Pricing of $850 Million of Senior Notes
• 02 Mar 2021
  Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics
• 02 Mar 2021
  Darlene Solomon Award Presented to University of Geneva Scientist Noemi Jiménez-Rojo
• 22 Feb 2021
  Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
• 18 Feb 2021
  Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
• 18 Feb 2021
  Agilent Ranks No. 2 on Barron’s List of America’s Most Sustainable Companies
• 17 Feb 2021
  Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis
• 16 Feb 2021
  Agilent Reports First-Quarter Fiscal Year 2021 Financial Results